Counselling issues in familial hypertrophic cardiomyopathy.
Open Access
- 1 March 1998
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 35 (3) , 183-188
- https://doi.org/10.1136/jmg.35.3.183
Abstract
To illustrate the variable clinical presentations and rates of progression in familial hypertrophic cardiomyopathy (FHC), phenotypes and genotypes were compared in three FHC families with different genetic defects. In the first family, the FHC abnormality was a protein truncating mutation (Gln969X) in the cardiac myosin binding protein C gene. The second family had a missense change (Asn755Lys) in the same gene. A missense mutation (Arg453Cys) in the cardiac beta myosin heavy chain gene was present in the third family. Penetrance associated with the Gln969X defect was 27% in the age range 0 to 40 years. This was considerably less than the 93% penetrance (0 to 40 years) observed in the two families with missense mutations. The variable penetrance in FHC, as well as the unpredictability of sudden cardiac death, complicates clinical diagnosis and management, including genetic counselling. Although a genetic disease with a predominantly adult onset, there are counselling issues in FHC which set it aside from other adult onset disorders.Keywords
This publication has 22 references indexed in Scilit:
- Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene.Journal of Medical Genetics, 1998
- Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathyNature Genetics, 1997
- DNA testing in familial hypertrophic cardiomyopathy: clinical and laboratory implicationsClinical Genetics, 1996
- Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscleNature Genetics, 1996
- Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3.Journal of Clinical Investigation, 1995
- Hypertrophic cardiomyopathy — pathology and pathogenesisHistopathology, 1995
- Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1994
- Should we test children for "adult" genetic diseases?The Lancet, 1990
- Equivocal and Borderline Myocardial Hypertrophy in Relatives of Patients with Hypertrophic Cardiomyopathy: Possible Implications in Genetics of the DiseaseCardiology, 1988
- Hypertrophic cardiomyopathy: an important cause of sudden death.Archives of Disease in Childhood, 1984